Jenburkt Pharmaceuticals Ltd vs Panjon Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Jenburkt Pharmaceuticals Ltd is ₹ 1074 as of 05 May 15:30 . The P/E Ratio of Jenburkt Pharmaceuticals Ltd changed from 11.1 on March 2021 to 13.9 on March 2025 . This represents a CAGR of 4.60% over 5 yearsThe P/E Ratio of Panjon Ltd changed from 22.4 on March 2023 to 97.8 on March 2025 . This represents a CAGR of 63.44% over 3 years The Market Cap of Jenburkt Pharmaceuticals Ltd changed from ₹ 182.84 crore on March 2021 to ₹ 446.49 crore on March 2025 . This represents a CAGR of 19.55% over 5 yearsThe Market Cap of Panjon Ltd changed from ₹ 27.28 crore on March 2022 to ₹ 38.6 crore on March 2025 . This represents a CAGR of 9.07% over 4 years The revenue of Jenburkt Pharmaceuticals Ltd for the Dec '25 is ₹ 44.84 crore as compare to the Sep '25 revenue of ₹ 47.64 crore. This represent the decline of -5.88% The revenue of Panjon Ltd for the Dec '25 is ₹ 14.18 crore as compare to the Sep '25 revenue of ₹ 14.99 crore. This represent the decline of -5.4% The ebitda of Jenburkt Pharmaceuticals Ltd for the Dec '25 is ₹ 9.24 crore as compare to the Sep '25 ebitda of ₹ 15.18 crore. This represent the decline of -39.13% The ebitda of Panjon Ltd for the Dec '25 is ₹ 0.33 crore as compare to the Sep '25 ebitda of ₹ 0.31 crore. This represent the growth of 6.45% The net profit of Jenburkt Pharmaceuticals Ltd changed from ₹ 7.42 crore to ₹ 5.93 crore over 7 quarters. This represents a CAGR of -12.02% The net profit of Panjon Ltd changed from ₹ 0.03 crore to ₹ 0.22 crore over 7 quarters. This represents a CAGR of 212.22% The Dividend Payout of Jenburkt Pharmaceuticals Ltd changed from 28.37 % on March 2021 to 24.76 % on March 2025 . This represents a CAGR of -2.69% over 5 yearsThe Dividend Payout of Panjon Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family.
The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries.
It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements.

About Panjon Ltd

Incorporated in Dec.'83 Panjon Limited became public in 1992.
The Company was promoted by Nagin Kothari and Manoj Kothari.
The Company is a leading FMCG company.
It has marked its presence with significant achievements and today commands a remarkable market status.
Panjon today has renowned products like PANJON Tablet , PANJON Balm , PANJON Inhaler, PANJON cough drops, Swad Digestive Drops, Swad Chatpati Drops, Swad Chyawanpra Candy,Percy Masala Candy, Panjon Swad PACHAK range : Shahi Anardana, Special Jeera Goli, Hing Peda, Albela Aam, Khatta Meetha Khajoor, Chatpata Amla, Chulbuli Imli and many more. The Company manufactures and markets consumer and pharmaceutical products which are low priced and within the reach of the common man.

FAQs for the comparison of Jenburkt Pharmaceuticals Ltd and Panjon Ltd

Which company has a larger market capitalization, Jenburkt Pharmaceuticals Ltd or Panjon Ltd?

Market cap of Jenburkt Pharmaceuticals Ltd is 459 Cr while Market cap of Panjon Ltd is 40 Cr

What are the key factors driving the stock performance of Jenburkt Pharmaceuticals Ltd and Panjon Ltd?

The stock performance of Jenburkt Pharmaceuticals Ltd and Panjon Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jenburkt Pharmaceuticals Ltd and Panjon Ltd?

As of May 5, 2026, the Jenburkt Pharmaceuticals Ltd stock price is INR ₹1042.2. On the other hand, Panjon Ltd stock price is INR ₹23.61.

How do dividend payouts of Jenburkt Pharmaceuticals Ltd and Panjon Ltd compare?

To compare the dividend payouts of Jenburkt Pharmaceuticals Ltd and Panjon Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.